BioCardia BCDA
NASDAQ BCDA
$1.08 -0.02 (-2.26%)
As of: Sep 10, 2026 · 1:49 PM EDT

BioCardia (BCDA) Sales of Property, Plant and Equipment (2011)

Analysis

BioCardia (BCDA) Sales of Property, Plant and Equipment (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Krystal Biotech 10.23 Bn 9.38 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - -
3 Iovance Biotherapeutics 3.64 Bn 3.35 Bn 55.72 Mn -
4 Legend Biotech 3.53 Bn 2.57 Bn 251.50 Mn -
5 uniQure 2.99 Bn 2.99 Bn 5.49 Mn -
6 Beam Therapeutics 2.52 Bn 2.52 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.14 Bn 1.35 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 BioCardia 13.00 Mn 8.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 560,000.00
Sep 30, 2011 -411,000.00